Shares of Bristol Myers Squibb Co. BMY slumped 0.55% to $58.37 Wednesday, on what proved to be an all-around great trading ...

An estimated 1 in 500 people in the U.S. are living with hypertrophic cardiomyopathy (HCM) -; the most common inherited heart disease -; and many are unaware.

Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...

Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...

Low- and middle-income countries (LMICs) are undergoing a significant health transformation. While once predominantly ...

LONDON (Reuters) - Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert ...

Bristol Myers Squibb Co. closed $2.39 below its 52-week high ($61.08), which the company reached on November 11th.

Artificial intelligence (AI) is changing the way companies do business -- helping programmers write code and fielding ...

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

RWJBarnabas Health appoints Steven Stylianos, MD as system director for pediatric surgery and surgeon-in-chief at Bristol-Myers Squibb Children's Hospital ...

BMS has been among the pharma giants that have bought into AI for drug discovery. In 2021, the company struck a $1.2 billion ...

Progression-free survival was improved among patients who received nivolumab and ipilimumab, and toxicity was generally greater among patients who received chemotherapy.